Compliance With an Antibiotic Guideline for Suspected Ventilator-Associated Infection: The Ventilator-Associated INfection (VAIN2) Study.
Journal
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653
Informations de publication
Date de publication:
01 10 2021
01 10 2021
Historique:
pubmed:
10
5
2021
medline:
25
2
2023
entrez:
9
5
2021
Statut:
ppublish
Résumé
To evaluate a guideline for antibiotic decisions in children with suspected ventilator-associated infection. Prospective, observational cohort study conducted in 22 PICUs in the United States and Canada. PICUs in 22 hospitals from April 2017 to January 2019. Children less than 3 years old on mechanical ventilation greater than 48 hours who had respiratory secretions cultured and antibiotics initiated for suspected ventilator-associated infection. After baseline data collection in children with suspected ventilator-associated infection (Phase 1), a consensus guideline was developed for advising antibiotic continuation or stopping at 48-72 hours (Phase 2) and implemented (Phase 3). Guideline-based antibiotic recommendations were provided to the treating clinicians once clinical and microbiologic data were available. Demographic and outcome data were collected, and guideline compliance and antibiotic utilization evaluated for Phase 1 and Phase 3. Despite education and implementation efforts, guideline-concordant antibiotic management occurred in 158 of 227 (70%) Phase 3 subjects compared with 213 of 281 (76%) in Phase 1. Illness severity and positive respiratory cultures were the primary determinants of antibiotic continuation. For subjects with a positive respiratory culture but a score for which antibiotic discontinuation was recommended (score ≤ 2), only 27% of Phase 3 subjects had antibiotics discontinued. Antibiotic continuation was not associated with improved outcomes in these subjects and was associated with significantly longer duration of ventilation (median 5.5 d longer) and PICU stay (5 d longer) in the overall study population. Positive respiratory cultures were not associated with outcomes irrespective of antibiotic treatment. Antibiotic guideline efficacy and safety remain uncertain due to clinician failure to follow the guideline, instead primarily relying on respiratory culture results. Strategies to overcome clinician perceptions of respiratory cultures and other barriers will be vital for improving guideline adherence and antibiotic use in suspected ventilator-associated infection in future studies.
Identifiants
pubmed: 33965989
doi: 10.1097/PCC.0000000000002761
pii: 00130478-202110000-00002
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
859-869Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Déclaration de conflit d'intérêts
Drs. Karsies’, Beardsley’s, Prentice’s, and Willson’s institutions received funding from Gerber Foundation. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Références
Fischer JE, Ramser M, Fanconi S: Use of antibiotics in pediatric intensive care and potential savings. Intensive Care Med 2000; 26:959–966
Geissler A, Gerbeaux P, Granier I, et al.: Rational use of antibiotics in the intensive care unit: Impact on microbial resistance and costs. Intensive Care Med 2003; 29:49–54
Mourani PM, Sontag MK: Ventilator-associated pneumonia in critically ill children: A new paradigm. Pediatr Clin North Am 2017; 64:1039–1056
Centers for Disease Control and Prevention: Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event. 2021. Available at: https://www.cdc.gov/nhsn/PDFs/pscManual/6pscVAPcurrent.pdf . Accessed April 26, 2021
Willson DF, Hoot M, Khemani R, et al.; Ventilator-Associated INfection (VAIN) Investigators and the Pediatric Acute Lung Injury and Sepsis Investigator’s (PALISI) Network: Pediatric ventilator-associated infections: The ventilator-associated infection study. Pediatr Crit Care Med 2017; 18:e24–e34
Willson DF, Kirby A, Kicker JS: Respiratory secretion analyses in the evaluation of ventilator-associated pneumonia: A survey of current practice in pediatric critical care. Pediatr Crit Care Med 2014; 15:715–719
Willson DF, Conaway M, Kelly R, et al.: The lack of specificity of tracheal aspirates in the diagnosis of pulmonary infection in intubated children. Pediatr Crit Care Med 2014; 15:299–305
Brusselaers N, Labeau S, Vogelaers D, et al.: Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: Systematic review and diagnostic test accuracy meta-analysis. Intensive Care Med 2013; 39:365–375
Durairaj L, Mohamad Z, Launspach JL, et al.: Patterns and density of early tracheal colonization in intensive care unit patients. J Crit Care 2009; 24:114–121
Baram D, Hulse G, Palmer LB: Stable patients receiving prolonged mechanical ventilation have a high alveolar burden of bacteria. Chest 2005; 127:1353–1357
Ewig S, Torres A, El-Ebiary M, et al.: Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med 1999; 159:188–198
Rello J, Ausina V, Ricart M, et al.: Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104:1230–1235
Beardsley AL, Nitu ME, Cox EG, et al.: An evaluation of various ventilator-associated infection criteria in a PICU. Pediatr Crit Care Med 2016; 17:73–80
Zilberberg MD, Shorr AF, Micek ST, et al.: Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: A single-center experience. Chest 2008; 134:963–968
Luna CM, Aruj P, Niederman MS, et al.; Grupo Argentino de Estudio de la Neumonía Asociada al Respirador group: Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006; 27:158–164
Iregui M, Ward S, Sherman G, et al.: Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122:262–268
Shein SL, Rotta AT, Slain KN, et al.: The authors reply. Pediatr Crit Care Med 2019; 20:796–798
Pollack MM, Patel KM, Ruttimann UE: PRISM III: An updated pediatric risk of mortality score. Crit Care Med 1996; 24:743–752
Leteurtre S, Duhamel A, Salleron J, et al.; Groupe Francophone de Réanimation et d’Urgences Pédiatriques (GFRUP): PELOD-2: An update of the pediatric logistic organ dysfunction score. Crit Care Med 2013; 41:1761–1773
Cabana MD, Rand CS, Powe NR, et al.: Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282:1458–1465
Fischer F, Lange K, Klose K, et al.: Barriers and strategies in guideline implementation-A Scoping Review. Healthcare (Basel) 2016; 4:E36
Miller MA, Bosk EA, Iwashyna TJ, et al.: Implementation challenges in the intensive care unit: The why, who, and how of daily interruption of sedation. J Crit Care 2012; 27:218.e1–218.e7
Anger KE, Szumita PM: Barriers to glucose control in the intensive care unit. Pharmacotherapy 2006; 26:214–228
Chastre J, Wolff M, Fagon JY, et al.; PneumA Trial Group: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 2003; 290:2588–2598
Klompas M, Li L, Menchaca JT, Gruber S, et al.: Ultra-short-course antibiotics for patients with suspected ventilator-associated pneumonia but minimal and stable ventilator settings. Clin Infect Dis 2017; 64:870–876
Kalil AC, Metersky ML, Klompas M, et al.: Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society. Clin Infect Dis 2016; 63:e61–e111